Mark Radetic, MD
Gastroenterology · Sarasota, FLNPI 1760915250
Payments from drug & device makers
Across 67 payments — averaging $95.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$3K
- Wilson Cook Medical Incorporated$884
- Cook Medical LLC$739
- Medtronic$668
- Madrigal Pharmaceuticals$271
- 3-d Matrix, Inc.$189
- plus $1K from 13 others
What the payments were for
- Travel & lodging$3,85660%
- Food & beverage$2,54440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 28 | $2,594 |
| Wilson Cook Medical Incorporated | 3 | $884 |
| Cook Medical LLC | 5 | $739 |
| Medtronic | 5 | $668 |
| Madrigal Pharmaceuticals | 2 | $271 |
| 3-d Matrix, Inc. | 1 | $189 |
| Gilead | 3 | $164 |
| Johnson & Johnson | 2 | $150 |
| Phathom Pharmaceuticals, Inc. | 2 | $125 |
| AbbVie | 6 | $124 |
| Merit Medical Systems Inc | 1 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $115 |
| Olympus America Inc. | 1 | $86 |
| Boston Scientific | 1 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Braintree Laboratories, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $22 |
| Amgen | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,400 in reported general payments places this provider in the 65th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 21 | $350 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $240 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Sarasota
- Guy NeffSarasota$17.6M
- Souvik SarkarSarasota$1.2M
- Howard SchwartzTavernier$38.8M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.